Walleye Capital
VOR icon

Walleye Capital’s Vor Biopharma VOR Stock Holding History

Walleye Capital’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-828
Closed -$39.2K – 6048
2024
Q1 		$39.2K Buy
+828
New +$36.4K ﹤0.01% 4755
2023
Q2 		– Sell
-823
Closed -$88.6K – 4923
2023
Q1 		$88.6K Sell
823
-7,346
-90% -$814K ﹤0.01% 2997
2022
Q4 		$1.09M Buy
+8,169
New +$808K 0.02% 955

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Walleye Capital's VOR Position: Q2 2024 in Review

Walleye Capital sold out of Vor Biopharma (VOR) in Q2 2024, closing a stake of 828 shares — an estimated $39.2K sold.

Walleye Capital first reported a position in VOR in Q4 2022 and held it in 3 quarters. The position peaked at $1.09M in Q4 2022. 71 funds tracked by Wall St. Rank hold VOR as of Q2 2024.

  • Walleye Capital reported no remaining Vor Biopharma position as of Q2 2024 after selling out during the quarter.
  • Walleye Capital sold 828 Vor Biopharma shares in Q2 2024, an estimated $39.2K.
  • Walleye Capital first reported a position in Vor Biopharma in Q4 2022 and held it in 3 quarters.
  • Walleye Capital's Vor Biopharma position peaked at $1.09M in Q4 2022.
  • 71 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2024.

Based on Walleye Capital's 13F filing for Q2 2024, filed 14 Aug 2024.